Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
CA 1340113 C · Owner: Abou-Gharbia, Magid A. · Inventors: Abou-Gharbia, Magid A.; Childers, Wayne E. Jr.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
There are disclosed compounds of the formula (I) (see fig. I), wherein R1 is 1-adamantyl 3-methyl-1-adamantyl, 3-noradamantyl, unsubstituted or substituted-2-indolyl 3-indolyl, 2-benzofuranyl and 3-benzofuranyl wherein the substituents are selected from lower alkyl lower alkoxy, and halo; R2 is unsubstituted or substituted phenyl benzyl, pyridinyl, pyrinidinyl or pyrazinyl wherein the, substituents are selected from lower alkyl lower alkoxy, trifluoromethyl ,and halo; R3 is H or lower alkyl of 1 to 3 carbon atoms; n is the integer 0 or 1; m is the integer from 2 to 5; and the pharmaceutically acceptable salts thereof. Compounds according the present invention have demonstrated usefulness as …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted November 3, 1998. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 3, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.